Floatz logo

5-FC

Colorectal Neoplasm

TransgenePhase 1/2Dormant
C
33/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
18/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Colorectal Neoplasm cohort.

Asset / SponsorPhaseRating
Capecitabine
Rutgers, The State University of New Jersey
Phase 4BBB
Ferric Carboxymaltose [Ferinject]
Nottingham University Hospitals NHS Trust
Phase 4BBB
Nivolumab
Bristol-Myers Squibb
Phase 3BB
FERRIC CATION
Nottingham University Hospitals NHS Trust
Phase 4BB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Nottingham University Hospitals NHS Trust
Phase 4BB

View all 25 →

Same molecule, other indications

5-FC is also rated in:

Glioblastoma MultiformeDormant
CC
Indicative ·
43 / 100
View asset →
Anaplastic AstrocytomaDormant
CC
Indicative ·
43 / 100
View asset →
Digestive System NeoplasmDormant
C
Indicative ·
33 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →